Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar continuous infusion plus chemotherapy as first-line treatment for advanced squamous non-small cell lung cancer
ChiCTR-IPR-17010441Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Wannan Medical College
- Start
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of endostar in Pulmonary squamous cell carcinoma, sponsored by The First Affiliated Hospital of Wannan Medical College. Primary endpoint: Objective response rate. Started Jan 2017; status: recruiting.
02
Drugs
endostar
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on ChiCTR-IPR-17010441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010441.